Citigroup
INDV

Citigroup’s Indivior Pharmaceuticals INDV Stock Holding History

Citigroup’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$997K Sell
27,823
-615,183
-96% -$23.2M ﹤0.01% 3320
2026
Q2 		$26.4M Buy
643,006
+588,521
+1,080% +$21.3M 0.01% 1015
2026
Q1 		$1.66M Sell
54,485
-37,562
-41% -$1.24M ﹤0.01% 2792
2025
Q4 		$3.3M Buy
92,047
+55,064
+149% +$1.68M ﹤0.01% 2313
2025
Q3 		$892K Sell
36,983
-161,378
-81% -$3.38M ﹤0.01% 3229
2025
Q2 		$2.95M Buy
198,361
+61,901
+45% +$721K ﹤0.01% 2340
2025
Q1 		$1.28M Sell
136,460
-859,865
-86% -$9.04M ﹤0.01% 3071
2024
Q4 		$12.8M Buy
996,325
+751,424
+307% +$7.73M 0.01% 1222
2024
Q3 		$2.42M Buy
244,901
+20,147
+9% +$236K ﹤0.01% 2495
2024
Q2 		$3.52M Sell
224,754
-42,632
-16% -$769K ﹤0.01% 1888
2024
Q1 		$5.72M Sell
267,386
-56,075
-17% -$1.05M ﹤0.01% 1612
2023
Q4 		$4.89M Buy
323,461
+169,693
+110% +$3.01M ﹤0.01% 1615
2023
Q3 		$3.34M Sell
153,768
-59,658
-28% -$1.36M ﹤0.01% 1651
2023
Q2 		$4.95M Buy
+213,426
New +$4.89M ﹤0.01% 1493

Other funds holding INDV

Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Citigroup's INDV Position: Q3 2026 in Review

Citigroup reduced its Indivior Pharmaceuticals (INDV) stake by 96% in Q3 2026, selling an estimated $23.2M and leaving 27,823 shares worth $997K. The position accounts for ﹤0.01% of the portfolio, ranked #3320.

Citigroup first reported a position in INDV in Q2 2023 and has held it in 14 quarters since. The position peaked at $26.4M in Q2 2026. 98 funds tracked by Wall St. Rank hold INDV as of Q3 2026.

  • Citigroup held 27,823 shares of Indivior Pharmaceuticals worth $997K as of Q3 2026.
  • Citigroup sold 615,183 Indivior Pharmaceuticals shares in Q3 2026, an estimated $23.2M.
  • Indivior Pharmaceuticals made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #3320 holding.
  • Citigroup first reported a position in Indivior Pharmaceuticals in Q2 2023 and has held it in 14 quarters since.
  • Citigroup's Indivior Pharmaceuticals position peaked at $26.4M in Q2 2026.
  • 98 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.